- Professor of Psychiatry
- Research Professor of Medicine
- davisjm [at] uic.edu
- (312) 413-4570
School of Public Health / Psychiatric Institute (SPHPI)
1601 W. Taylor St.
SPHPI MC 912
Chicago IL 60612
- Room #:508
Dr. Davis been involved in depression research since the early formulations of the biogenic amine hypothesis of depression in 1965 in collaboration with Bunney. He was one of the first few researchers in psychopharmacology, and wrote one of the earliest texts in collaboration with Don Klein. He was the first to do meta-analysis in psychiatry in 1975, on maintenance treatment with antipsychotics, mood stabilizers, and antidepressants. At present, he is interested in the role of the omega-3 essential fatty acids in health and diseases. He continues to be active in meta-analysis of psychotropic drugs, including Omega-3 fatty acids in depression, and the role of fatty acids in the prevention of heart attacks and strokes.
Clinical trials, meta-analysis, biochemical and epigenetic basis of mental illness, child development, obesity, the role of nutrition in mental illness, heart attacks and strokes.
The ALSPAC longitudinal study of children of the 1990s, the clinical trials program of The Stanley Medical Research Institute, a collaborative US and China investigation into the prodrome of schizophrenia.
Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013 Sep 14;382(9896):951-62.
Klein, Donald F. and Davis, John M.: Diagnosis and Drug Treatment of Psychiatric Disorders. Williams and Wilkins, Baltimore, 1969
Ramsden CE, Zamora D, Leelarthaepin B, Majchrzak-Hong SF, Faurot KR, Suchindran CM, Ringel A, Davis JM, Hibbeln JR. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: Evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. 5 February 2013. BMJ 346:e8707.
Davis, J.M. Overview: Maintenance therapy in psychiatry: I. Schizophrenia. Amer. J. Psychiatry 132(12):1237-1245, 1975.
Ramsden CE, Hibbeln JR, Majchrzak SF, Davis JM. n-6 fatty acid specific and mixed polyunsaturated dietary interventions have different effects on CHD risk: a meta-analysis of randomized controlled trials. British Journal of Nutrition 2010; 104(11), 1586-600.
Hibbeln JR, Davis JM, Steer C, Emmett P, Rogers I, Williams C, Golding J. Maternal seafood consumption in pregnancy and neurodevelopment outcomes in childhood (ALSPAC study): an observational cohort study. Lancet 2007; 369: 578-85.
Leucht S, Corves C, Arbter D, Engel RR, Chunbo L, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet; 2008;373(9657):31-41.
Janowsky, D.S., El-Yousef, M.K., Davis, J.M., and Sekerke, H.J. A cholinergic-adrenergic hypothesis of mania and depression. Lancet 2(778):632-635, September 23, 1972.
Javaid, J.I., Fischman, M., Schuster, C.R., Dekirmenjian, H., and Davis, J.M. Cocaine plasma concentration: relation to physiological and subjective effects in humans. Science 202:227-228, 1978.
Bunney, W.E., Jr., and Davis, J.M. Norepinephrine in depressive reactions. Arch. Gen. Psychiat. 13(6):483-494, 1965.
Tamminga CA, Davis JM. (1978) Schizophrenic symptoms improve with apomorphine. Science 200:567-568.
|06/26/2018||Congratulations to Dr. John Davis who has been selected as the 2018 Recipient of the COM Pioneer in Medicine Award||UIC College of Medicine|
|11/07/2017||Dr. John Davis - winner of the Lieber Prize in Outstanding Achievement in Schizophrenia Research given by the Brain and Behavior Research Foundation||UIC Today|